David Shaw’s Amedisys AMED Stock Holding History

David Shaw’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,500	Closed	-$344K	–	4532
2025 Q2	$344K	Hold	3,500	–	–	﹤0.01%	3806
2025 Q1	$324K	Hold	3,500	–	–	﹤0.01%	3731
2024 Q4	$318K	Buy	+3,500	New	+$321K	﹤0.01%	3857
2022 Q2	–	Sell	-10,000	Closed	-$1.72M	–	5311
2022 Q1	$1.72M	Sell	10,000 -1,500	-13%	-$224K	﹤0.01%	3444
2021 Q4	$1.86M	Buy	+11,500	New	+$1.85M	﹤0.01%	3414
2020 Q3	–	Sell	-10,000	Closed	-$1.99M	–	3797
2020 Q2	$1.99M	Hold	10,000	–	–	﹤0.01%	2410
2020 Q1	$1.83M	Buy	+10,000	New	+$1.78M	﹤0.01%	2237
2019 Q1	–	Sell	-13,000	Closed	-$1.52M	–	3568
2018 Q4	$1.52M	Buy	+13,000	New	+$1.53M	﹤0.01%	2369
2015 Q1	–	Sell	-20,000	Closed	-$587K	–	3604
2014 Q4	$587K	Hold	20,000	–	–	﹤0.01%	3211
2014 Q3	$403K	Buy	+20,000	New	+$386K	﹤0.01%	3512
2014 Q1	–	Sell	-20,000	Closed	-$293K	–	4250
2013 Q4	$293K	Hold	20,000	–	–	﹤0.01%	4071
2013 Q3	$344K	Buy	+20,000	New	+$297K	﹤0.01%	3825

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

David Shaw's AMED Position: Q3 2024 in Review

David Shaw sold out of Amedisys (AMED) in Q3 2024, closing a stake of 3,078 shares — an estimated $283K sold.

David Shaw first reported a position in AMED in Q2 2013 and held it in 45 quarters. The position peaked at $97.4M in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

David Shaw reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
David Shaw sold 3,078 Amedisys shares in Q3 2024, an estimated $283K.
David Shaw first reported a position in Amedisys in Q2 2013 and held it in 45 quarters.
David Shaw's Amedisys position peaked at $97.4M in Q3 2021.
286 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.